About Enhancer
| Enhancer ID: | E_02_0700 |
| Species: | mouse |
| Position : | chr9:14371056-14373056   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | -- |
| Pubmed ID: | 32286279 |
| Enhancer experiment: | Immunostaining?RNA-seq?ChIP-seq |
| Enhancer experiment description: | TADs are further removed until the 2-cell stage before being progressively reestablished.Obvious defects including stronger TAD boundaries, aberrant super-enhancer and promoter interactions are found in SCNT embryos. |
About Target gene
| Target gene : | Kdm4d |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | TADs are further removed until the 2-cell stage before being progressively reestablished.Obvious defects including stronger TAD boundaries, aberrant super-enhancer and promoter interactions are found in SCNT embryos. |
About TF
| TF name : | -- |
| TF experiment: | Immunostaining?RNA-seq?ChIP-seq |
| TF experiment description: | TADs are further removed until the 2-cell stage before being progressively reestablished.Obvious defects including stronger TAD boundaries, aberrant super-enhancer and promoter interactions are found in SCNT embryos. |
About Function
| Enhancer function : | TADs are further removed until the 2-cell stage before being progressively reestablished.Obvious defects including stronger TAD boundaries, aberrant super-enhancer and promoter interactions are found in SCNT embryos. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
TADs are further removed until the 2-cell stage before being progressively reestablished.Obvious defects including stronger TAD boundaries, aberrant super-enhancer and promoter interactions are found in SCNT embryos. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene